Advertisement

U.S. markets closed

S&P Futures
5,884.00
-3.00(-0.05%)
Dow Futures
43,497.00
-14.00(-0.03%)
Nasdaq Futures
20,353.50
-14.50(-0.07%)
Russell 2000 Futures
2,293.00
-4.70(-0.20%)
Crude Oil
70.95
+0.28(+0.40%)
Gold
2,712.40
+4.90(+0.18%)

Pasithea Therapeutics Corp. (KTTA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

3.9900

+0.0200

(+0.50%)

At close: 04:00PM EDT

4.2000

+0.21

(+5.26%)

After hours:

05:25PM EDT

Loading interactive chart...

GlobeNewswire
Pasithea Therapeutics Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other cancer indications, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 1,219,513 shares of its common stock (or pre-funded warrants in lieu thereof), accompanyin
Premium
MT Newswires
Sector Update: Health Care Stocks Mixed Late Afternoon
Sector Update: Health Care Stocks Mixed Late Afternoon